Sun Pharma Q4 profit falls 37% to Rs 399.8 crore on one-time loss; revenue ahead of estimates
The stock fell 19 percent during the quarter largely due to COVID-19-led market correction, but it gained 11 percent in the last one year, 6.3 percent year-to-date and 42 percent from March lows.